2005
DOI: 10.1016/j.clon.2005.04.009
|View full text |Cite
|
Sign up to set email alerts
|

Testicular Sex Cord–Stromal Tumours: The Edinburgh Experience 1988–2002, and a Review of the Literature

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
43
0

Year Published

2007
2007
2024
2024

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(44 citation statements)
references
References 34 publications
1
43
0
Order By: Relevance
“…5,8,9 Among testicular neoplasms, it has been reported that Leydig cell tumors frequently present with gynecomastia, with the incidence reported as 15%-30%. 8,10 Testicular germ cell tumors, including seminoma and teratoma, can also present with gynecomastia, particularly in cases of tumors secreting β-HCG, which stimulates estrogen synthesis in normal Leydig cells. 5,11,12 Thus, the possibility of a testicular tumor should be considered in all male patients presenting with gynecomastia.…”
Section: Discussionmentioning
confidence: 99%
“…5,8,9 Among testicular neoplasms, it has been reported that Leydig cell tumors frequently present with gynecomastia, with the incidence reported as 15%-30%. 8,10 Testicular germ cell tumors, including seminoma and teratoma, can also present with gynecomastia, particularly in cases of tumors secreting β-HCG, which stimulates estrogen synthesis in normal Leydig cells. 5,11,12 Thus, the possibility of a testicular tumor should be considered in all male patients presenting with gynecomastia.…”
Section: Discussionmentioning
confidence: 99%
“…29 Neoplasms from either Leydig or Sertoli cells of the testicular interstitium account for 10-30% of malignant tumors in pediatric patients. [29][30][31] Leukemia or lymphoma account for less than 10% of testicular masses; such masses can be bilaterally distributed. 32 Primary leukemia of the testis is rare.…”
Section: 28mentioning
confidence: 99%
“…The cytomorphology of the tumour cells of the large-cell calcifying SCT, for example, displays greater similarity to the Leydig than to the Sertoli cells. SCT also do not have a specific immunostaining profile: they react mostly positive with vimentin antibodies (90%), followed by cytokeratin (80%) and to a variable extent with inhibin (30-90%), calretinin (33%) and S100 (30-60%) [2,3,12,17,20]. The tumour cells are invariably negative for placental alkaline phosphatase (PLAP), alpha-fetoprotein and human chorion gonadotropin.…”
Section: Introductionmentioning
confidence: 96%